Latest European Expansion News

Page 1 of 7
LGP Cannatrek generated A$4.4 million in net operating cash flow on unaudited quarterly revenue of A$26.0 million, providing the first clean look at the merged group’s operations. Cost synergies, Danish production upgrades and UK expansion are advancing, while a pending TGA penalty remains an unresolved risk.
Ada Torres
Ada Torres
30 Oct 2026
Energy One has completed its acquisition of European energy software business GMSL, issuing 7,089,780 shares to Fluxys in the process. Fluxys is now Energy One’s largest shareholder and has secured a board seat through nominee director Erik Vennekens.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.
Ada Torres
Ada Torres
13 Oct 2026
Vection Technologies has secured a multi-year framework agreement with Italian telecommunications provider Retelit Digital Service, which has committed to generate at least approximately A$19.5 million in revenue for the company by June 2030. The deal expands Vection’s route into enterprise customers across Italy and Europe, although margins and payment terms remain undisclosed.
Sophie Babbage
Sophie Babbage
13 Oct 2026
Memphasys has signed a three-year exclusive distribution agreement covering the Czech Republic, Slovakia and Kazakhstan, with minimum purchases worth approximately A$674,000. The deal expands Felix’s European footprint while adding dedicated commercial leadership in the region.
Victor Sage
Victor Sage
18 Sept 2026
AML3D Limited surged to a record $12.5 million revenue in FY26, delivering its first half-year EBITDA profit and locking in a $29 million order book driven by US Defence contracts and UK market entry.
Victor Sage
Victor Sage
31 Aug 2026
OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.
Ada Torres
Ada Torres
28 Aug 2026
4DMedical’s CT:VQ™ lung imaging technology secured FDA clearance and CMS reimbursement, driving rapid adoption in top US medical centres and expanding its addressable market to $3 billion with new clinical programs and European contracts.
Ada Torres
Ada Torres
28 Aug 2026
Control Bionics has secured MHRA registration for its NeuroStrip device, unlocking commercial supply in Great Britain and launching early trials with leading UK institutions.
Ada Torres
Ada Torres
25 Aug 2026
Genetic Signatures narrowed its FY2026 net loss by 30% to $14 million amid a strategic overhaul, signing a key 10-year supply deal with Denmark’s Hvidovre Hospital and resetting its US market approach.
Ada Torres
Ada Torres
25 Aug 2026
4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.
Ada Torres
Ada Torres
31 July 2026
xReality Group delivered a robust Q4 FY26, with cash receipts up 46% to $6.9 million and net operating cash flow rising 64% to $2.2 million. The company completed a $5.6 million US Department of Defense project on time and secured its first European contract with the Swedish Armed Forces.
Sophie Babbage
Sophie Babbage
29 July 2026

Browse the archive

Full archive